• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪甲苷通过 TGF-β/Smad 信号通路抑制外阴鳞癌细胞增殖。

Astragaloside IV inhibits cell proliferation in vulvar squamous cell carcinoma through the TGF-β/Smad signaling pathway.

机构信息

Department of Gynecology, The First Affiliated Hospital of China Medical University, China Medical University, Shenyang, Liaoning, P.R. China.

Department of Biochemistry and Molecular Biology, China Medical University, Shenyang, Liaoning, P.R. China.

出版信息

Dermatol Ther. 2019 Jul;32(4):e12802. doi: 10.1111/dth.12802. Epub 2019 Jan 7.

DOI:10.1111/dth.12802
PMID:30536730
Abstract

OBJECTIVE

To explore the inhibition of the proliferation of vulvar squamous cell carcinoma (VSCC) by astragaloside IV.

METHODS

MTT examined the cell proliferation of VSCC. Flow cytometry analyzed cell cycle and apoptosis. Western blot assay detected the expression of some relevant proteins.

RESULTS

AS-IV reduced the proliferation of SW962 cells in a concentration- and time-dependent manner, induced cell-cycle arresting in G0/G1 phase, as demonstrated by the up-regulation of P53 and P21 expression, and the down-regulation of cyclin D1 expression. AS-IV enhanced the expression of Bax and cleaved-caspase 3, and suppressed Bcl-2 and Bcl-xl expression, which resulted in apoptosis increased. Furthermore, the expression of Beclin-1 and LC3-B was upregulated and that of P62 was downregulated, which suggested that AS-IV could increase the incidence of autophagy in SW962 cells. After inhibiting autophagy by 3-methyladenine (3-MA), cell apoptosis decreased upon AS-IV treatment. Similarly, TGF-β1 stimulated SW962 cells, cell proliferation enhanced, and the expression of TGF-βRII and Smad4 was decreased. Furthermore, the expression of proteins that promote apoptosis and autophagy decreased. After AS-IV treatment, the expression levels of the above proteins exhibited the opposite effect.

CONCLUSION

AS-IV inhibits cell proliferation and induces apoptosis and autophagy through the TGF-β/Smad signaling pathway in VSCC.

摘要

目的

探讨黄芪甲苷(AS-IV)对外阴鳞癌细胞(VSCC)增殖的抑制作用。

方法

采用 MTT 法检测 VSCC 细胞增殖,流式细胞术分析细胞周期和凋亡,Western blot 检测相关蛋白表达。

结果

AS-IV 呈浓度和时间依赖性抑制 SW962 细胞增殖,上调 P53 和 P21 表达、下调 cyclin D1 表达,诱导细胞周期阻滞于 G0/G1 期。AS-IV 增强 Bax 和 cleaved-caspase 3 的表达,抑制 Bcl-2 和 Bcl-xl 的表达,导致细胞凋亡增加。此外,Beclin-1 和 LC3-B 的表达上调,P62 的表达下调,表明 AS-IV 可增加 SW962 细胞自噬的发生。用 3-甲基腺嘌呤(3-MA)抑制自噬后,AS-IV 处理时细胞凋亡减少。同样,TGF-β1 刺激 SW962 细胞,细胞增殖增强,TGF-βRII 和 Smad4 的表达减少,促进凋亡和自噬的蛋白表达减少。AS-IV 处理后,上述蛋白的表达水平呈现相反的效果。

结论

AS-IV 通过 TGF-β/Smad 信号通路抑制 VSCC 细胞增殖,并诱导细胞凋亡和自噬。

相似文献

1
Astragaloside IV inhibits cell proliferation in vulvar squamous cell carcinoma through the TGF-β/Smad signaling pathway.黄芪甲苷通过 TGF-β/Smad 信号通路抑制外阴鳞癌细胞增殖。
Dermatol Ther. 2019 Jul;32(4):e12802. doi: 10.1111/dth.12802. Epub 2019 Jan 7.
2
Astragaloside IV inhibits cell invasion and metastasis in vulvar squamous cell carcinoma through the TGF-β1/FAK/AKT signaling pathway.黄芪甲苷通过 TGF-β1/FAK/AKT 信号通路抑制外阴鳞癌细胞侵袭和转移。
Ginekol Pol. 2022;93(3):179-184. doi: 10.5603/GP.a2021.0113. Epub 2021 Jul 15.
3
[Explore the mechanism of astragaloside IV-PESV on proliferation, migration, and autophagy of prostate cancer cells based on the PI3K/AKT signaling pathway].基于PI3K/AKT信号通路探讨黄芪甲苷-聚乙二醇化丝素蛋白纳米粒对前列腺癌细胞增殖、迁移及自噬的作用机制
Zhonghua Nan Ke Xue. 2023 Dec;29(12):963-972.
4
Astragaloside IV Induces Apoptosis, G-Phase Arrest and Inhibits Anti-apoptotic Signaling in Hepatocellular Carcinoma.黄芪甲苷诱导肝癌细胞凋亡、G1 期阻滞并抑制抗凋亡信号通路。
In Vivo. 2020 Mar-Apr;34(2):631-638. doi: 10.21873/invivo.11817.
5
The role of cofilin-l in vulvar squamous cell carcinoma: A marker of carcinogenesis, progression and targeted therapy.卷曲相关蛋白-1 在外阴鳞状细胞癌中的作用:一种致癌、进展和靶向治疗的标志物。
Oncol Rep. 2016 May;35(5):2743-54. doi: 10.3892/or.2016.4625. Epub 2016 Feb 17.
6
Effect of astragaloside IV on cognitive dysfunction in rats with cerebrally infarcted via TGF-β / Smad signaling pathway.黄芪甲苷通过 TGF-β/Smad 信号通路对脑梗死大鼠认知功能障碍的影响。
Cell Mol Biol (Noisy-le-grand). 2020 May 15;66(2):87-92.
7
Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.高良姜素通过激活转化生长因子-β受体/ Smad信号通路抑制肝癌细胞HepG2的增殖。
Toxicology. 2014 Dec 4;326:9-17. doi: 10.1016/j.tox.2014.09.010. Epub 2014 Sep 28.
8
Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.黄芪甲苷通过抑制柯萨奇病毒 B3 诱导的心肌病中的 TGF-β1 信号通路减轻心肌纤维化。
Eur J Pharmacol. 2011 May 11;658(2-3):168-74. doi: 10.1016/j.ejphar.2011.02.040. Epub 2011 Mar 1.
9
Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.和厚朴酚通过诱导细胞凋亡、细胞周期阻滞和自噬抑制口腔鳞状细胞癌细胞的体外和体内生长。
J Cell Mol Med. 2018 Mar;22(3):1894-1908. doi: 10.1111/jcmm.13474. Epub 2018 Jan 24.
10
AST IV inhibits H₂O₂-induced human umbilical vein endothelial cell apoptosis by suppressing Nox4 expression through the TGF-β1/Smad2 pathway.AST IV通过TGF-β1/Smad2途径抑制Nox4表达,从而抑制H₂O₂诱导的人脐静脉内皮细胞凋亡。
Int J Mol Med. 2015 Jun;35(6):1667-74. doi: 10.3892/ijmm.2015.2188. Epub 2015 Apr 17.

引用本文的文献

1
Metabolites of Astragalus membranaceus and their pro-apoptotic and cytotoxic activities: insights into targeted metabolic pathways.黄芪的代谢产物及其促凋亡和细胞毒性活性:对靶向代谢途径的见解
Front Pharmacol. 2025 Aug 29;16:1647958. doi: 10.3389/fphar.2025.1647958. eCollection 2025.
2
Molecular mechanisms of astragaloside-IV in hepatocellular carcinoma therapy: a systematic review.黄芪甲苷在肝细胞癌治疗中的分子机制:一项系统综述
BMC Cancer. 2025 Sep 1;25(1):1407. doi: 10.1186/s12885-025-14758-w.
3
Astragaloside IV: a potential nemesis for gastric cancer.
黄芪甲苷IV:胃癌的潜在克星。
Front Pharmacol. 2025 Jul 18;16:1636341. doi: 10.3389/fphar.2025.1636341. eCollection 2025.
4
Research Progress on the Anti-Cancer Effects of Saponins and Their Mechanisms of Action.皂苷的抗肿瘤作用及其作用机制的研究进展。
Molecules. 2024 Jul 18;29(14):3388. doi: 10.3390/molecules29143388.
5
Astragaloside IV Attenuates Programmed Death-Ligand 1-Mediated Immunosuppression during Liver Cancer Development via the miR-135b-5p/CNDP1 Axis.黄芪甲苷IV通过miR-135b-5p/CNDP1轴减轻肝癌发生过程中程序性死亡配体1介导的免疫抑制。
Cancers (Basel). 2023 Oct 19;15(20):5048. doi: 10.3390/cancers15205048.
6
AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy.黄芪甲苷通过抑制自噬增强丙泊酚对非小细胞肺癌细胞的抗肿瘤作用。
Open Med (Wars). 2023 Sep 25;18(1):20230799. doi: 10.1515/med-2023-0799. eCollection 2023.
7
Mechanism exploration and prognosis study of Astragali Radix-Spreading hedyotis herb for the treatment of lung adenocarcinoma based on bioinformatics approaches and molecular dynamics simulation.基于生物信息学方法和分子动力学模拟的黄芪-白花蛇舌草治疗肺腺癌的作用机制探索与预后研究
Front Chem. 2023 Mar 29;11:1128671. doi: 10.3389/fchem.2023.1128671. eCollection 2023.
8
Astragaloside IV, as a potential anticancer agent.黄芪甲苷IV,作为一种潜在的抗癌药物。
Front Pharmacol. 2023 Feb 17;14:1065505. doi: 10.3389/fphar.2023.1065505. eCollection 2023.
9
Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments.通过超高效液相色谱-质谱联用、网络药理学和体内实验鉴定艾迪注射液治疗胰腺癌的关键药理成分及靶点。
Chin Med. 2023 Jan 14;18(1):7. doi: 10.1186/s13020-023-00710-2.
10
Anticancer effects and mechanisms of astragaloside‑IV (Review).黄芪甲苷的抗癌作用及其机制(综述)。
Oncol Rep. 2023 Jan;49(1). doi: 10.3892/or.2022.8442. Epub 2022 Nov 11.